N-acetyltransferase Gene Variants Involved in Pediatric Idiosyncratic Drug-Induced Liver Injury

被引:0
作者
Ales-Palmer, Maria Luisa [1 ,2 ]
Andujar-Vera, Francisco [3 ]
Iglesias-Baena, Ivan [4 ]
Munoz-de-Rueda, Paloma [5 ]
Ocete-Hita, Esther [1 ,2 ,6 ]
机构
[1] Univ Granada, Dept Pediat, Granada 18016, Spain
[2] Virgen de las Nieves Univ Hosp, Dept Pediat, Granada 18014, Spain
[3] Inst Invest Biosanitaria ibs GRANADA, Bioinformat Unit, Granada 18012, Spain
[4] GenAct Clin & Res, Res Unit, Granada 18193, Spain
[5] Inst Invest Biosanitaria ibs GRANADA, Res Support Unit, Granada 18012, Spain
[6] Inst Invest Biosanitaria ibs GRANADA, Granada 18012, Spain
关键词
DILI; whole-exome sequencing; risk factors; hepatotoxicity; liver injury; children; NAT-2; polymorphism; NAT2; PHARMACOGENETICS; POLYMORPHISMS; SULFAMETHOXAZOLE; HEPATOTOXICITY; SUSCEPTIBILITY; PREDICTION; OVERWEIGHT; INFANTS; OBESE;
D O I
10.3390/biomedicines12061288
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Idiosyncratic drug-induced liver injury (DILI) is a complex multifactorial disease in which the toxic potential of the drug, together with genetic and acquired factors and deficiencies in adaptive processes, which limit the extent of damage, may determine susceptibility and make individuals unique in their development of hepatotoxicity. In our study, we sequenced the exomes of 43 pediatric patients diagnosed with DILI to identify important gene variations associated with this pathology. The result showed the presence of two variations in the NAT2 gene: c.590G>A (p.Arg197Gln) and c.341T>C (p.Ile114Thr). These variations could be found separately or together in 41 of the 43 patients studied. The presence of these variations as a risk factor for DILI could confirm the importance of the acetylation pathway in drug metabolism.
引用
收藏
页数:13
相关论文
共 35 条
[1]   Drug-induced liver injury:: An analysis of 461 incidences submitted to the Spanish Registry over a 10-year period [J].
Andrade, RJ ;
Lucena, MI ;
Fernández, MC ;
Pelaez, G ;
Pachkoria, K ;
García-Ruiz, E ;
García-Munoz, B ;
González-Grande, R ;
Pizarro, A ;
Durán, JA ;
Jiménez, M ;
Rodrigo, L ;
Romero-Gomez, M ;
Navarro, JM ;
Planas, R ;
Costa, J ;
Borras, A ;
Soler, A ;
Salmerón, J ;
Martin-Vivaldi, R .
GASTROENTEROLOGY, 2005, 129 (02) :512-521
[2]   Exome sequencing as a tool for Mendelian disease gene discovery [J].
Bamshad, Michael J. ;
Ng, Sarah B. ;
Bigham, Abigail W. ;
Tabor, Holly K. ;
Emond, Mary J. ;
Nickerson, Deborah A. ;
Shendure, Jay .
NATURE REVIEWS GENETICS, 2011, 12 (11) :745-755
[3]   Influence of NAT2 Genotype and Maturation on Isoniazid Exposure in Low-Birth-Weight and Preterm Infants With or Without Human Immunodeficiency Virus (HIV) Exposure [J].
Beranger, Agathe ;
Bekker, Adrie ;
Solans, Belen P. ;
Cotton, Mark F. ;
Mirochnick, Mark ;
Violari, Avy ;
Wang, Jiajia ;
Cababasay, Mae ;
Wiesner, Lubbe ;
Browning, Renee ;
Moye, Jack ;
Capparelli, Edmund, V ;
Savic, Radojka M. .
CLINICAL INFECTIOUS DISEASES, 2022, 75 (06) :1037-1045
[4]   N-acetyltransferase 2 genetic polymorphisms and anti-tuberculosis-drug-induced liver injury: a correlation study [J].
Cheng, Fang ;
Jiang, Xian-Gao ;
Zheng, Shi-Lin ;
Wu, Te ;
Zhang, Qiang ;
Ye, Xin-Chun ;
Liu, Saiduo ;
Shi, Ji-Chan .
FRONTIERS IN PHARMACOLOGY, 2023, 14
[5]   N-Acetyltransferase 2, glutathione S-transferase gene polymorphisms and susceptibility to hepatocellular carcinoma in an Algerian population [J].
Chorfi, Lamia ;
Fercha, Azzedine ;
Derouiche, Faouzia ;
Sebihi, Fatima Zohra ;
Houhou, Dallal ;
Chorfi, Keltoum ;
Bendjemana, Katia .
XENOBIOTICA, 2022, 52 (01) :99-104
[6]  
Chung H, 2018, PLOS ONE, V13, DOI [10.1371/Journal.pone.0191258, 10.1371/journal.pone.0191258]
[7]   RUCAM in Drug and Herb Induced Liver Injury: The Update [J].
Danan, Gaby ;
Teschke, Rolf .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (01)
[8]   NAT2 global landscape: Genetic diversity and acetylation statuses from a systematic review [J].
Gutierrez-Virgen, Jorge E. ;
Pina-Pozas, Maricela ;
Hernandez-Tobias, Esther A. ;
Taja-Chayeb, Lucia ;
Lopez-Gonzalez, Ma. de Lourdes ;
Meraz-Rios, Marco A. ;
Gomez, Rocio .
PLOS ONE, 2023, 18 (04)
[9]   Fractal Geometry and the Pharmacometrics of Micafungin in Overweight, Obese, and Extremely Obese People [J].
Hall, Ronald G. ;
Swancutt, Mark A. ;
Gumbo, Tawanda .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2011, 55 (11) :5107-5112
[10]   Weight Drives Caspofungin Pharmacokinetic Variability in Overweight and Obese People: Fractal Power Signatures beyond Two-Thirds or Three-Fourths [J].
Hall, Ronald G., II ;
Swancutt, Mark A. ;
Meek, Claudia ;
Leff, Richard ;
Gumbo, Tawanda .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (05) :2259-2264